Customers of US retinal imaging and diagnostic company IRIS will be able to use AEYE-DS from Israel’s AEYE (see here previously) for the autonomous detection of diabetic retinopathy.

https://www.prnewswire.com/news-releases/iris-and-aeye-health-announce-partnership-to-provide-ai-screening-to-market-301874034.html